Skip to main content

Home/ Health affairs/ Group items tagged Healthcare-technology

Rss Feed Group items tagged

Alex Parker

GlaxoSmithKline Manufacturing Facility Expansion, Boronia - Pharmaceutical Technology - 1 views

  •  
    GlaxoSmithKline (GSK) announced the expansion of its manufacturing facility in Boronia, in the outer eastern suburbs of Melbourne, Australia, in November 2014. The expansion will introduce the latest machinery, which will be used for manufacturing advanced aseptic packing of sterile pharmaceutical liquids.
insightscare

Heart Care Special Edition | Insights Care - 0 views

  •  
    Insights Care Magazine we bring you "Heart Care Special Edition." This magazine contains a listing of some of the most prominent and advanced heart care centers, hospitals, diagnostic centers with specialization in heart care and technology companies working on specialized medical devices to assist in monitoring heart health.
P3 Healthcare Solutions

Looking Back At EHR Meaningful Use From A New Perspective - 0 views

  •  
    Its emphasis on the implementation of EHR technology throughout the USA. Moreover, it is also in accordance with the MIPS quality measure Promoting Interoperability (PI) in which physicians use innovative methods to improve the quality of care services.
P3 Healthcare Solutions

The Impact of Technology on Medical Billing and Coding - 0 views

  •  
    Medical billing and coding have undergone various changes. At first, the payment transaction methods were not clear. Then from the late eighties to until a decade ago, billers and coders had to write down every single detail manually on papers. The information collected was cipher into the designated codes or electronic codes to be stored in the hospital's database.
pharmacybiz

Nivedita Valentine:Pharmanovia appoints as VP - 0 views

  •  
    The life cycle management company, Pharmanovia, has appointed Nivedita Valentine as associate vice president of Product Innovation. Ms Valentine will oversee the company's product innovation operations and decision-making as Pharmanovia continues to focus efforts on both, identifying new prospects to enhance lifecycle management of its brands through incremental innovation. She will report to interim chief scientific officer Stephen Deacon and help bridge unmet patient needs with the help of novel therapies, originating both from in-house development and through partnerships. Ms Valentine currently holds positions on the value-added medicines committee within Medicines for Europe and the International Rare Diseases Research Consortium (IRDiRC) Task Force on Drug Repurposing Guidebook. Pharmanovia CEO Dr James Burt commented: "Digitalisation and utilising the latest technological innovation are notable areas of acceleration within the pharma industry and Nivedita's appointment will ensure iconic brands will continue to be improved, supported, and used sustainably.
Alex Parker

Aegis awarded its first patent for oral delivery of nucleotide-based drugs - 0 views

  •  
    Aegis Therapeutics has been awarded its first patent for oral delivery of nucleotide analog based drugs based upon the company's patented Intravail transmucosal absorption enhancer technology
Alex Parker

DARPA's vaccine manufacturing challenge - 0 views

  •  
    The prospect of global pandemic is worrying for public health authorities, with the sufficient supply of vaccines a particular concern. In the US, DARPA's Blue Angel project has been working on alternative plant-based vaccine production methods, with impressive results.
Alex Parker

CHA announces new program to accelerate innovation in life sciences and health care - 0 views

  •  
    Published 25 February 2014 Cambridge Healthtech Associates (CHA) has announced a new program to accelerate innovation in life sciences and health care. Announcing the launch of the first-ever tool in life sciences and health care to evaluate and rank new technologies and services via an end-user process.
Alex Parker

Goodwin, Aspyrian partner for cGMP manufacturing of new antibody drug conjugate - 1 views

  •  
    PBR Staff Writer Published 25 March 2014 US-based Goodwin Biotechnology has entered into an agreement with Aspyrian Therapeutics for the technology transfer, process development, scale-up, and cGMP manufacturing of a new Antibody Drug Conjugate (ADC) for use in Phase I clinical trials.
Alex Parker

Better together? Combining therapies to slow down cancer growth - 1 views

  •  
    A pioneering study looking into the possibility of combining existing therapies to slow down cancer growth is showing encouraging early results. Elly Earls reports. A first-of-its-kind medical study at The Care Oncology Clinic on Harley Street, London, has started work on evaluating whether the use of a combination of safe, tolerable, existing, generic therapies could slow down cancer growth and improve survival times in patients for whom other treatments are no longer available or working.
aureabiolab2017

Acujoint- Nutraceutical Product for Joint Pain Treatment - 1 views

  •  
    Acujoint is a highly efficient formulation with natural bio actives used for joint pain treatment. It is made by patent pending PNS Technology for maintaining healthy joints.
Alex Parker

China food service industry: What are the current trends? - 1 views

  •  
    China's food industry is rapidly changing. As its population continues to grow, foodservice operators have to meet new consumer demands as tastes are changing and becoming westernised, and new technology is being introduced to the foodservice industry.
Alex Parker

Digital health intervention companies in ESMO 2019 conference - 1 views

  •  
    Digital health interventions (DHIs) are fast emerging as vital tools to promote personal health and provide essential services. DHIs can be accessed through mobile phones, tablets and computers, as well as serve as effective support systems to improve personal health.
P3 Healthcare Solutions

How to React to a Cybersecurity Attack Under HIPAA? - 0 views

  •  
    In this age of technology, we have to monitor computer systems very closely because cyber-attacks are just waiting to happen. Cybersecurity
P3 Healthcare Solutions

4 Things to Consider before Adopting Health IT Innovation - 0 views

  •  
    With MIPS 2020 just around the corner, eligible clinicians are ready to submit quality data to CMS in order to improve their financial situation. We all are rooting for quality healthcare services, and technology incorporation is an efficient way to achieve this goal. For the same reason, MIPS eligible clinicians from all specialties are adopting
P3 Healthcare Solutions

MIPS 2021: All About the Promoting Interoperability Measures - 2 views

  •  
    MIPS has elevated the way Medicare part B providers get compensated. Each category, including Promoting Interoperability, has specific measures and guidelines that need to be fulfilled for MIPS 2021 reporting.
croservices

Tech-Enabled Contract Research Organization | Vial CRO - 1 views

  •  
    Vial is a technology enabled Contract Research Organization (CRO) that delivers faster, higher quality trial outcomes.
« First ‹ Previous 61 - 77 of 77
Showing 20 items per page